Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma - PubMed (original) (raw)
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma
Luigi Bolondi et al. Hepatology. 2005 Jul.
Abstract
In a prospective study, we examined the impact of arterial hypervascularity, as established by the European Association for the Study of the Liver (EASL) recommendations, as a criterion for characterizing small (1-3 cm) nodules in cirrhosis. A total of 72 nodules (1-2 cm, n = 41; 2.1-3 cm, n = 31) detected by ultrasonography in 59 patients with cirrhosis were included in the study. When coincidental arterial hypervascularity was detected at contrast perfusional ultrasonography and helical computed tomography, the lesion was considered to be hepatocellular carcinoma (HCC) according to EASL criteria. When one or both techniques showed negative results, ultrasound-guided biopsy was performed. In cases with negative results for malignancy or high-grade dysplasia, biopsy was repeated when an increase in size was detected at the 3-month follow-up examination. Coincidental hypervascularity was found in 44 of 72 nodules (61%; 44% of 1-2-cm nodules and 84% of 2-3-cm nodules). Fourteen nodules (19.4%) had negative results with both techniques (hypovascular nodules). Biopsy showed HCC in 5 hypovascular nodules and in 11 of 14 nodules with hypervascularity using only one technique. All nodules larger than 2 cm finally resulted to be HCC. Not satisfying the EASL imaging criteria for diagnosis were 38% of HCCs 1 to 2 cm (17% hypovascular) and 16% of those 2 to 3 cm (none hypovascular). In conclusion, the noninvasive EASL criteria for diagnosis of HCC are satisfied in only 61% of small nodules in cirrhosis; thus, biopsy frequently is required in this setting. Relying on imaging techniques in nodules of 1 to 2 cm would miss the diagnosis of HCC in up to 38% of cases. Any nodule larger than 2 cm should be regarded as highly suspicious for HCC.
Comment in
- Diagnosis of small hepatocellular carcinoma.
Sherman M. Sherman M. Hepatology. 2005 Jul;42(1):14-6. doi: 10.1002/hep.20790. Hepatology. 2005. PMID: 15962322 Review. No abstract available.
Similar articles
- Validation of an extension of the international non-invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis.
Sorrentino P, Tarantino L, D'Angelo S, Terracciano L, Ferbo U, Bracigliano A, Panico L, De Chiara G, Lepore M, De Stefano N, Fiorentino F, Vecchione R. Sorrentino P, et al. J Gastroenterol Hepatol. 2011 Apr;26(4):669-77. doi: 10.1111/j.1440-1746.2010.06564.x. J Gastroenterol Hepatol. 2011. PMID: 21054520 - Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI. Yoo HJ, et al. Invest Radiol. 2009 Dec;44(12):800-7. doi: 10.1097/RLI.0b013e3181bc271d. Invest Radiol. 2009. PMID: 19838119 - The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
Leoni S, Piscaglia F, Golfieri R, Camaggi V, Vidili G, Pini P, Bolondi L. Leoni S, et al. Am J Gastroenterol. 2010 Mar;105(3):599-609. doi: 10.1038/ajg.2009.654. Epub 2009 Nov 24. Am J Gastroenterol. 2010. PMID: 19935786 - Management of small hepatocellular carcinoma.
Leoni S, Piscaglia F, Righini R, Bolondi L. Leoni S, et al. Acta Gastroenterol Belg. 2006 Apr-Jun;69(2):230-5. Acta Gastroenterol Belg. 2006. PMID: 16929622 Review. - Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
Kim TK, Lee KH, Khalili K, Jang HJ. Kim TK, et al. Abdom Imaging. 2011 Jun;36(3):244-63. doi: 10.1007/s00261-011-9686-0. Abdom Imaging. 2011. PMID: 21253723 Review.
Cited by
- Surveillance for hepatocellular carcinoma in a mixed-aetiology UK cohort with cirrhosis: does α-fetoprotein still have a role?
Webb GJ, Wright KV, Harrod EC, Gorard DA, Collier JD, Evans AK. Webb GJ, et al. Clin Med (Lond). 2015 Apr;15(2):139-44. doi: 10.7861/clinmedicine.15-2-139. Clin Med (Lond). 2015. PMID: 25824065 Free PMC article. - Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm).
Mei Q, Yu M, Chen Q. Mei Q, et al. World J Clin Cases. 2022 Aug 26;10(24):8525-8534. doi: 10.12998/wjcc.v10.i24.8525. World J Clin Cases. 2022. PMID: 36157793 Free PMC article. - Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
Vidili G, Arru M, Solinas G, Calvisi DF, Meloni P, Sauchella A, Turilli D, Fabio C, Cossu A, Madeddu G, Babudieri S, Zocco MA, Iannetti G, Di Lembo E, Delitala AP, Manetti R. Vidili G, et al. World J Gastroenterol. 2022 Jul 21;28(27):3488-3502. doi: 10.3748/wjg.v28.i27.3488. World J Gastroenterol. 2022. PMID: 36158272 Free PMC article. - Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT.
Golfieri R, Marini E, Bazzocchi A, Fusco F, Trevisani F, Sama C, Mazzella G, Cavuto S, Piscaglia F, Bolondi L. Golfieri R, et al. Radiol Med. 2009 Dec;114(8):1239-66. doi: 10.1007/s11547-009-0439-x. Epub 2009 Aug 20. Radiol Med. 2009. PMID: 19697104 - Functional imaging of hepatocellular carcinoma.
Hoogenboom TC, Thursz M, Aboagye EO, Sharma R. Hoogenboom TC, et al. Hepat Oncol. 2016 Apr;3(2):137-153. doi: 10.2217/hep-2015-0005. Epub 2016 Mar 29. Hepat Oncol. 2016. PMID: 30191034 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical